Malaria is a disease that can make the mankind terribly ill and thus suffer from different types of symptoms, for instance fever, body chills and many more. It has been seen as a deadly disease as well. There is a specific approach to curb malaria. Scientists have successfully developed a technique in which they did some alteration in gut genes to spread the antimalarial genes to the next generation. Antimalarial genes are extracted from mosquitoes and can provide a proper cure for malaria. In this study, researchers did a lot of effort and hence highly experts were doing this study and were able to make proper reports of the same. This study was published on most of the online platforms and it was also published in eLife. The risk of malaria is increasing in past years and hence doctors are finding different types of techniques through which it can be cured easily without fail.
Researchers used CRISPR-Cas9 gene which they can completely edit genes and mold according to them. In mosquitoes, they have a special ability to spread malaria and through this ability, they harm many people and they have to spend a lot of money for their treatment. If we go and see the rural areas people are not able to get a proper cure for it and so telehealth is a great solution here which provides the medical consultancy just by a call. It is a brand new way to provide less illness in people.
Developing mosquito protection from pesticides, just as malaria parasite protection from antimalarial drugs, has made a pressing requirement for better approaches to battle the sickness. Gene drives are being tried as another methodology. They work by making hereditarily changed mosquitoes that, when delivered into the climate, would spread qualities that either decrease mosquito populaces or make the creepy crawlies less inclined to spread the malaria parasite. Yet, researchers should demonstrate that this methodology is protected and viable before delivering hereditarily adjusted mosquitoes into nature. Gene drives are promising apparatuses for malaria control, says first creator Astrid Hoermann, Research Associate at Imperial College London, U.K.
